Ken Griffin Ideaya Biosciences, Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 30,700 shares of IDYA stock, worth $637,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,700

Previous 14,200 116.2%

Holding current value

$637,332

Previous $449,000 75.5%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.79 - $31.98 $19.4 Million - $25.1 Million	784,449 Added 74.54%	1,836,830 $47.2 Million
Q3 2024 Nov 14, 2024	SELL	$30.37 - $43.05 $13 Million - $18.4 Million	-426,942 Reduced 28.86%	1,052,381 $33.3 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $1.65 Million - $2.08 Million	47,877 Added 3.34%	1,479,323 $51.9 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $7.25 Million - $9.98 Million	-211,847 Reduced 12.89%	1,431,446 $62.8 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $22.1 Million - $32.2 Million	898,193 Added 120.55%	1,643,293 $58.5 Million
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $8.6 Million - $12.2 Million	-408,329 Reduced 35.4%	745,100 $20.1 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $1.9 Million - $3.63 Million	142,313 Added 14.07%	1,153,429 $27.1 Million
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $1.68 Million - $2.33 Million	124,257 Added 14.01%	1,011,116 $13.9 Million
Q4 2022 Feb 14, 2023	SELL	$14.47 - $18.17 $5.32 Million - $6.68 Million	-367,829 Reduced 29.32%	886,859 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $4.93 Million - $8.43 Million	533,644 Added 74.01%	1,254,688 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $2.98 Million - $5 Million	360,452 Added 99.96%	721,044 $9.95 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $4.03 Million - $8.66 Million	360,592 New	360,592 $4.04 Million
Q1 2021 May 17, 2021	SELL	$13.48 - $23.77 $381,969 - $673,546	-28,336 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $344,849 - $496,446	28,336 New	28,336 $397,000
Q3 2020 Nov 16, 2020	SELL	$11.22 - $14.46 $2.78 Million - $3.59 Million	-248,005 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $890,337 - $4.61 Million	248,005 New	248,005 $3.52 Million

Others Institutions Holding IDYA

# of Institutions

216

Shares Held

82.4M

Call Options Held

23.1K

Put Options Held

6.7K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $998M
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account